• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Increased influenza-specific antibody avidity in HIV-infected females compared to HIV-infected males on antiretroviral therapy

tetano

Editor, Senior Moderator
AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002022. [Epub ahead of print]
[h=1]Increased influenza-specific antibody avidity in HIV-infected females compared to HIV-infected males on antiretroviral therapy.[/h] Luo Z[SUP]1[/SUP], Ogunrinde E[SUP]1[/SUP], Li M[SUP]1[/SUP], Zhang L[SUP]2[/SUP], Martin L[SUP]3[/SUP], Zhou Z[SUP]1[/SUP], Hu Z[SUP]1,[/SUP][SUP]4[/SUP], Zhang T[SUP]1,[/SUP][SUP]5[/SUP], Li Z[SUP]1,[/SUP][SUP]6[/SUP], Zhang J[SUP]1,[/SUP][SUP]7[/SUP], Su B[SUP]6[/SUP], Zhang T[SUP]6[/SUP], Wu H[SUP]6[/SUP], Ma L[SUP]8[/SUP], Liao G[SUP]8[/SUP], Eckard AR[SUP]3,[/SUP][SUP]9[/SUP], Westerink MAJ[SUP]3[/SUP], Heath S[SUP]10[/SUP], Jiang W[SUP]1,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] : It is recommended that HIV-infected individuals receive annual influenza vaccination due to their high susceptibility to influenza infection, especially among females. However, there have been few studies investigating sex-related responses to influenza vaccine in antiretroviral (ART)-treated HIV-infected subjects. In this study, 26 aviremic ART-treated HIV-infected subjects and 16 healthy controls were enrolled in the current study. Blood was collected prior to vaccination (D0), on days 7-10 (D7), and on days 14-21 (D14) following administration of the 2013-2014 seasonal influenza vaccine. A series of analyses evaluated the serological and cellular responses following influenza vaccination. Female HIV-infected subjects had increased influenza-specific antibody avidity relative to male HIV-infected subjects, but similar plasma levels of influenza-specific binding antibodies and neutralizing antibodies. Increased cycling B cells and follicular helper CD4+ T (Tfh) cells were observed in female HIV-infected subjects pre- and post-vaccination compared to male HIV-infected subjects, and cycling Tfh cells were directly correlated with influenza-specific antibody avidity. Moreover, plasma testosterone levels were inversely correlated with antibody avidity index. The magnitude of microbial translocation (plasma lipopolysaccharide (LPS)) level was directly correlated with influenza-specific antibody avidity. Circulating 16S rDNA microbiome showed that enrichment of specific species within Proteobacteria was associated with influenza-specific antibody avidity. These results, including differences based on sex and correlations, were only observed in HIV+ subjects but not in the healthy controls. This study demonstrated sex differences in influenza-specific antibody avidity in ART-treated HIV disease, and provides valuable information on vaccination strategy in the ART-treated HIV-infected population.


PMID: 30234599 DOI: 10.1097/QAD.0000000000002022
 
Back
Top Bottom